Archive - January 2023
Milestone product launch for Kelso Pharma
Domestic Violence: DSVA Tasks Religious Leaders on Pre-Marital Counselling
1 in 8 Older Americans May Be ‘Junk Food Addicts,’ Poll Finds
Vertex and CRISPR Therapeutics Announce MHRA Marketing Authorisation Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa-cel
Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
Bristol Myers Squibb’s plaque psoriasis treatment recommended by CHMP
Sandoz’s high concentration Hyrimoz formulation recommended for use in EU
BEXIMCO PHARMACEUTICALS LIMITED Half Year Results 2022-23